102 related articles for article (PubMed ID: 30878031)
1. Iatrogenic Damage of Eye Tissues: Current Problems and Possible Solutions.
Baksheeva VE; Gancharova OS; Tiulina VV; Iomdina EN; Zamyatnin AA; Philippov PP; Zernii EY; Senin II
Biochemistry (Mosc); 2018 Dec; 83(12):1563-1574. PubMed ID: 30878031
[TBL] [Abstract][Full Text] [Related]
2. Mitochondria-targeted antioxidant SKQ1 protects cornea from oxidative damage induced by ultraviolet irradiation and mechanical injury.
Zernii EY; Gancharova OS; Tiulina VV; Zamyatnin AA; Philippov PP; Baksheeva VE; Senin II
BMC Ophthalmol; 2018 Dec; 18(1):336. PubMed ID: 30587174
[TBL] [Abstract][Full Text] [Related]
3. Environmental light and endogenous antioxidants as the main determinants of non-cancer ocular diseases.
Saccà SC; Roszkowska AM; Izzotti A
Mutat Res; 2013; 752(2):153-171. PubMed ID: 23337404
[TBL] [Abstract][Full Text] [Related]
4. Reactive Oxygen Species and the Aging Eye: Specific Role of Metabolically Active Mitochondria in Maintaining Lens Function and in the Initiation of the Oxidation-Induced Maturity Onset Cataract--A Novel Platform of Mitochondria-Targeted Antioxidants With Broad Therapeutic Potential for Redox Regulation and Detoxification of Oxidants in Eye Diseases.
Babizhayev MA; Yegorov YE
Am J Ther; 2016; 23(1):e98-117. PubMed ID: 21048433
[TBL] [Abstract][Full Text] [Related]
5. Mitochondria-Targeted Antioxidant SkQ1 Prevents Anesthesia-Induced Dry Eye Syndrome.
Zernii EY; Gancharova OS; Baksheeva VE; Golovastova MO; Kabanova EI; Savchenko MS; Tiulina VV; Sotnikova LF; Zamyatnin AA; Philippov PP; Senin II
Oxid Med Cell Longev; 2017; 2017():9281519. PubMed ID: 29158874
[TBL] [Abstract][Full Text] [Related]
6. The Eye, Oxidative Damage and Polyunsaturated Fatty Acids.
Saccà SC; Cutolo CA; Ferrari D; Corazza P; Traverso CE
Nutrients; 2018 May; 10(6):. PubMed ID: 29795004
[TBL] [Abstract][Full Text] [Related]
7. Suppression of Light-Induced Oxidative Stress in the Retina by Mitochondria-Targeted Antioxidant.
Baksheeva VE; Tiulina VV; Tikhomirova NK; Gancharova OS; Komarov SV; Philippov PP; Zamyatnin AA; Senin II; Zernii EY
Antioxidants (Basel); 2018 Dec; 8(1):. PubMed ID: 30577635
[TBL] [Abstract][Full Text] [Related]
8. The effect of thiamine pyrophosphate on ethambutol-induced ocular toxicity.
Cinici E; Cetin N; Ahiskali I; Suleyman B; Altuner D; Alp HH; Sener E; Calik I; Suleyman H
Cutan Ocul Toxicol; 2016 Sep; 35(3):222-7. PubMed ID: 26339826
[TBL] [Abstract][Full Text] [Related]
9. Mitochondria induce oxidative stress, generation of reactive oxygen species and redox state unbalance of the eye lens leading to human cataract formation: disruption of redox lens organization by phospholipid hydroperoxides as a common basis for cataract disease.
Babizhayev MA
Cell Biochem Funct; 2011 Apr; 29(3):183-206. PubMed ID: 21381059
[TBL] [Abstract][Full Text] [Related]
10. Hypercholesterolemia-induced ocular disorder: Ameliorating role of phytotherapy.
El-Sayyad HI; Elmansi AA; Bakr EH
Nutrition; 2015; 31(11-12):1307-16. PubMed ID: 26429651
[TBL] [Abstract][Full Text] [Related]
11. Antioxidant mechanism of mitochondria-targeted plastoquinone SkQ1 is suppressed in aglycemic HepG2 cells dependent on oxidative phosphorylation.
Ježek J; Engstová H; Ježek P
Biochim Biophys Acta Bioenerg; 2017 Sep; 1858(9):750-762. PubMed ID: 28554565
[TBL] [Abstract][Full Text] [Related]
12. Novel function of VEGF-B as an antioxidant and therapeutic implications.
Chen R; Lee C; Lin X; Zhao C; Li X
Pharmacol Res; 2019 May; 143():33-39. PubMed ID: 30851357
[TBL] [Abstract][Full Text] [Related]
13. Options for Topical Treatment of Oxidative Eye Diseases with a Special Focus on Retinopathies.
Russo C; Rusciano D; Santangelo R; Malaguarnera L
Medicina (Kaunas); 2024 Feb; 60(3):. PubMed ID: 38541080
[TBL] [Abstract][Full Text] [Related]
14. Enhancing the efficacy of AREDS antioxidants in light-induced retinal degeneration.
Wong P; Markey M; Rapp CM; Darrow RM; Ziesel A; Organisciak DT
Mol Vis; 2017; 23():718-739. PubMed ID: 29062223
[TBL] [Abstract][Full Text] [Related]
15. Bioactivation antioxidant and transglycating properties of N-acetylcarnosine autoinduction prodrug of a dipeptide L-carnosine in mucoadhesive drug delivery eye-drop formulation: powerful eye health application technique and therapeutic platform.
Babizhayev MA
Drug Test Anal; 2012 Jun; 4(6):468-85. PubMed ID: 21416634
[TBL] [Abstract][Full Text] [Related]
16. Preventive and therapeutic effects of SkQ1-containing Visomitin eye drops against light-induced retinal degeneration.
Novikova YP; Gancharova OS; Eichler OV; Philippov PP; Grigoryan EN
Biochemistry (Mosc); 2014 Oct; 79(10):1101-10. PubMed ID: 25519068
[TBL] [Abstract][Full Text] [Related]
17. Mitochondria-targeted antioxidant SkQ1 reduces age-related alterations in the ultrastructure of the lacrimal gland.
Bakeeva LE; Eldarov CM; Vangely IM; Kolosova NG; Vays VB
Oncotarget; 2016 Dec; 7(49):80208-80222. PubMed ID: 27852065
[TBL] [Abstract][Full Text] [Related]
18. Oxidative photodegradation of ocular tissues: beneficial effects of filtering and exogenous antioxidants.
Hammond BR; Johnson BA; George ER
Exp Eye Res; 2014 Dec; 129():135-50. PubMed ID: 25236792
[TBL] [Abstract][Full Text] [Related]
19. An attempt to prevent senescence: a mitochondrial approach.
Skulachev VP; Anisimov VN; Antonenko YN; Bakeeva LE; Chernyak BV; Erichev VP; Filenko OF; Kalinina NI; Kapelko VI; Kolosova NG; Kopnin BP; Korshunova GA; Lichinitser MR; Obukhova LA; Pasyukova EG; Pisarenko OI; Roginsky VA; Ruuge EK; Senin II; Severina II; Skulachev MV; Spivak IM; Tashlitsky VN; Tkachuk VA; Vyssokikh MY; Yaguzhinsky LS; Zorov DB
Biochim Biophys Acta; 2009 May; 1787(5):437-61. PubMed ID: 19159610
[TBL] [Abstract][Full Text] [Related]
20. Effects of lutein and zeaxanthin on aspects of eye health.
Ma L; Lin XM
J Sci Food Agric; 2010 Jan; 90(1):2-12. PubMed ID: 20355006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
